ABVC Biopharma Inc (ABVC) — Capital Reinvestment Ratio
Latest as of September 2024:
0.00x
ABVC Biopharma Inc (ABVC) has a Capital Reinvestment Ratio of 0.00x as of September 2024, meaning it reinvests 0% of its operating cash flow ($171.72K) in capital expenditures ($3.00). See ABVC Biopharma Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$171.72K
USD
Capital Expenditures
$3.00
USD
Data as of
Sep 2024
Most recent filing
ABVC Biopharma Inc Capital Reinvestment Ratio (2014–2014)
This chart tracks ABVC Biopharma Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for ABVC Biopharma Inc (2014–2014)
Year-by-year Capital Reinvestment Ratio for ABVC Biopharma Inc from 2014 to 2014. For live market cap and broader valuation context, see ABVC stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2014 | 16.73x | $1.17K | $19.55K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow